Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells.

Zou X, Li T, Mao Y, Zhu M, Chen X, Niu J, Dong T, Jiang J, Yang X

Open source

DOI
10.1155/2022/6441179
Published
2022
Container
BioMed research international
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/6441179,
  title = {Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells.},
  author = {Zou X and Li T and Mao Y and Zhu M and Chen X and Niu J and Dong T and Jiang J and Yang X},
  year = {2022},
  journal = {BioMed research international},
  doi = {10.1155/2022/6441179},
  url = {https://doi.org/10.1155/2022/6441179}
}

RIS

TY  - JOUR
TI  - Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells.
AU  - Zou X
AU  - Li T
AU  - Mao Y
AU  - Zhu M
AU  - Chen X
AU  - Niu J
AU  - Dong T
AU  - Jiang J
AU  - Yang X
PY  - 2022
JO  - BioMed research international
DO  - 10.1155/2022/6441179
UR  - https://doi.org/10.1155/2022/6441179
ER  - 

APA

X, Z., T, L., Y, M., M, Z., X, C., J, N., T, D., J, J., & X, Y. (2022). Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells.. BioMed research international. https://doi.org/10.1155/2022/6441179

Source records